the international research foundation

The International Research Foundation for English Language Education

The International Research Foundation for English Language Education  (TIRF) is a nonprofit organization whose mission is to promote research and best practices that inform and enrich English language education in multilingual contexts. IRF applies research findings to practical language problems by working collaboratively with teachers, researchers, authors and more.

Other facilities include an online the free  NewsLetter ‘FIRF TODAY’ and a  reference lists on various topics of interest to teachers, researchers, applied linguists, program administrators, and so on.

We highlight here its overview of Journals in language teaching and applied linguistics

Advertisement

An official website of the United States government

Here's how you know

Official websites use .gov A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS. A lock ( Lock Locked padlock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

International Research Experiences for Students (IRES)

View guidelines, important information about nsf’s implementation of the revised 2 cfr.

NSF Financial Assistance awards (grants and cooperative agreements) made on or after October 1, 2024, will be subject to the applicable set of award conditions, dated October 1, 2024, available on the NSF website . These terms and conditions are consistent with the revised guidance specified in the OMB Guidance for Federal Financial Assistance published in the Federal Register on April 22, 2024.

Important information for proposers

All proposals must be submitted in accordance with the requirements specified in this funding opportunity and in the NSF Proposal & Award Policies & Procedures Guide (PAPPG) that is in effect for the relevant due date to which the proposal is being submitted. It is the responsibility of the proposer to ensure that the proposal meets these requirements. Submitting a proposal prior to a specified deadline does not negate this requirement.

Supports international research and research-related activities for U.S. science and engineering students.

The International Research Experiences for Students (IRES) program supports international research and research-related activities for U.S. science and engineering students. The IRES program contributes to development of a diverse, globally engaged workforce with world-class skills. IRES focuses on active research participation by undergraduate and/or graduate students in high quality international research, education and professional development experiences in NSF-funded research areas.

The overarching, long-term goals of the IRES program are to enhance U.S. leadership in science and engineering research and education and to strengthen economic competitiveness through training the next generation of science research leaders. IRES focuses on the development of a world-class U.S. STEM workforce through international research experiences for cohorts of U.S. students.

Student participants supported by IRES funds must be citizens, nationals, or permanent residents of the United States.

Students do not apply directly to NSF to participate in IRES activities. Students apply to NSF-funded investigators who receive IRES awards. To identify appropriate IRES projects, students should consult the directory of active IRES awards .

All PIs, co-PIs and Senior Personnel on IRES proposals must be from U.S. based organizations. Personnel from international partners should be listed as "non-NSF funded collaborators." Guidance on information to provide for "non-NSF funded collaborators" is found in Section V.A.

IRES projects engage a group of undergraduate and/or graduate students in active high-quality collaborative research, in principle at an international site with mentorship from international researchers. IRES projects must be organized around a coherent overarching intellectual theme that may involve a single discipline or multiple disciplines funded by NSF.

For all IRES proposals, PIs are strongly encouraged to outline a variety of virtual, hybrid or other alternative approaches to strengthen and maintain international collaboration in addition to travel.  It is expected that these approaches will extend collaboration beyond the actual international trip and strengthen IRES proposals overall.

Updates and announcements

Ires program virtual office hours (august - october 2024), program contacts.

Program Director

	[email protected]	OD/OISE
Program Director		[email protected]	OD/OISE
Program Director		[email protected]	OD/OISE

Program events

• September 9, 2024 - IRES Program Virtual Office Hours
• September 19, 2024 - IRES Program Virtual Office Hours
• September 23, 2024 - IRES Program Virtual Office Hours
• October 3, 2024 - IRES Program Virtual Office Hours
• October 7, 2024 - IRES Program Virtual Office Hours
• October 17, 2024 - IRES Program Virtual Office Hours
• October 21, 2024 - IRES Program Virtual Office Hours
• August 29, 2024 - IRES Program Virtual Office Hours
• August 12, 2024 - IRES Program Virtual Office Hours
• August 1, 2024 - IRES Program Virtual Office Hours
• January 22, 2024 - IRES Program Virtual Office Hours FY24

Additional program resources

• Frequently Asked Questions (FAQs) for International Research Experiences for Students (IRES) (NSF 24-506)
• IRES resources for current and potential PIs (site hosted by Virginia Tech; content provided by VT & Purdue)

Awards made through this program

Organization(s).

• Office of International Science and Engineering (OD/OISE)

Advancing the Science of Incentives and Motivation

Through research.

Browse through our extensive library of research on non-cash rewards, incentive travel, motivational meetings and recognition.

Access the IRF’s recent, relevant and impactful research

Driving Growth Through Total Rewards

Business leaders recognize that to keep their best talent, they must invest in competitive compensation and benefits packages. These benefits are often communicated to employees and prospects as part of a Total Rewards package.

The State Of International Incentives 

The IRF, in conjunction with The Plam Beaches, gathered a group of corporate incentive program owners and third-party incentive house executives from Europe and Canada to discuss their primary influencers and drivers of incentive destination decisions.

2024 Attendee Preferences For Incentive Travel

This study explores trends in attendee preferences, factors in destination selection, and how incentive travel program design can impact employee motivation.

AI: Uses and Possibilities for Incentives Professionals

The IRF conducted a series of focus groups with suppliers, third parties and program owners who shared their insights, practical use cases, and hesitation around AI technology. 

IRF 2024 Trends Report 

As we enter 2024, incentive professionals are called to transform incentive programs with new rewards and experiences in a challenging economic environment.

2024 Service Awards Winners Announced

Bich-Lien Kaldahl received the Outstanding Service to IRF Award, Joe Fijol  was named Volunteer of the Year at the 2024 Invitational.

IRF Webinar: The Sate of International Incentives

During our next IRF webinar on September 10, European and Canadian incentive planners will discuss their priorities, challenges, and decision drivers for incentive travel programs. They will also share their perspectives on the US as an incentive destination. Register now

Recent Research

Workplace motivation.

IRF Webinar: Driving Growth Through Total Rewards

Academic Research in Action: Differences in Workplace Reward Preference and Outcomes: Men vs. Women

recognition

IRF Webinar: Attendee Preferences for Incentive Travel

Featured Partners

For information on available research partnerships, please contact  [email protected] .

IRF Updates Sign Up

Email Address*

First Name*

Industry Role* —Please choose an option— End-user / Program Owner Third Party Buyer Supplier Media Academic/Research Other

Supplier Role* —Please choose an option— Hotel Merchandise Gift Card CVB DMC Other

Where are you based?* —Please choose an option— North America Europe Asia Pacific Latin America and the Caribbean Africa

I consent to receive IRF updates and announcements via email. For further information, please consult the Privacy Policy.

Support IFER

Apply for a Grant

• Scientific Advisory Board
• Graduate Fellowships Current Fellows Past Recipients

Funding the Future of Ethical Science

IFER is leading the way to advance new paths to replace and reduce the use of animals in research and testing.

Supporting Ethical Research Since 1985

Grants Awarded

Grants Renewed

Grant Recipients

Forging a humane approach to science

We believe there is a better way to advance scientific research and produce results without bringing harm to animals. This belief is what has been driving our mission for more than 35 years. Each year we award funding to early career scientists who are developing or using alternatives to animal models and testing protocols. Supporting smarter science means developing and utilizing innovative and human relevant solutions to replace animals in research and testing.

This is the Time

Technology advances are driving less need for and reliance on using animals for testing and research. In the United States, a commitment has been made by the National Institutes of Health (NIH) to continue the development of non-animal model alternative methods, [1] and the Environmental Protection Agency (EPA) has prioritized efforts to reduce animal testing. [2]

Benefits in Clinical Trials Questioned

Studies using animals have not always led to further knowledge or development of treatments affecting human health. Animal research often fails in human trials, never making it into clinical practice. [3]

Animal Studies are Flawed

It is difficult to recreate human diseases in animals due to the discrepancies of accurately replicating the human body in another species. This could lead to harming humans and delay finding effective treatments and therapies. [4]

Funding the Future

We believe that supporting researchers developing innovative, human-relevant model systems will lead to better science. This will save animal lives and human lives as well. This next generation of researchers  is working to make a true difference.

Compassionate Scientific Research

The research projects that are selected by IFER for funding comprise human health and safety issues affecting people of any age. Research conducted by recent and past recipients  has involved studies in chronic illnesses, long term diseases and developmental disorders.

Success stories

Investing in the Future of Ethical Research

Each year we award the IFER Graduate Fellowships for Alternatives to the Use of Animals in Science to early career scientists. This funding supports projects that utilize modern and emerging technologies to replace the use of animals in biomedical and basic research, safety testing, environmental testing, and education, as well as projects that involve noninvasive behavioral studies of animals in their natural habitats.

"Engineered in vitro model of the human kidney for blood filtration and disease modeling"

Xingrui Mou

2020 - 2023

“Reliance on animal models in preclinical studies may contribute, in part, to the copious failed clinical trials related to Alzheimer’s therapy. I believe a human disease model is necessary to uncover the subtleties of the disease mechanism that may be necessary for therapeutic design. Overall, the use of pluripotent stem cells allows us to address many experimental questions that would otherwise require numerous animals to examine.”

Nicholas Brookhouser

2017 - 2020

“Humane scientific research is the future. The revolutionary shift towards non-animal and non-cancer tissue cell lines has had a positive impact on reducing animal research. Human-relevant models can help us study mechanisms, disease pathways or genetic risk factors which, with the aid of computational tools, can be translated to human therapies, preventive measures and epidemiological findings.”

Georgina Harris

2013 - 2017

What Our Fellowship Recipients Say

"If we as a society have decided that animals have rights and value as living, breathing creatures, then our research and our application of science should also reflect that."

Johns Hopkins University, Baltimore, Maryland

"Presently, researchers use animals ranging from mice and rats to ferrets and pigs. In addition to ethical concerns of using these animals, these models typically involve performing challenging surgical procedures that are difficult to reproduce. And the results from these models cannot be easily translated to humans."

Prashant Hariharan

Wayne State University, Detroit, Michigan

“Ultimately, if we can create perfect or near-perfect human tissues and organs in the lab from scratch, those can be used instead of animals in applications such as drug testing and biomedical research.”

Michael Ferguson

Boston University

For Students

Our fellowships provide up to $12,500 annually toward the cost of supplies and the recipient’s salary or tuition per year. The fellowships are renewable for up to three years. Continued funding is dependent on student progress and availability of funds.

Your investment in IFER will pay huge dividends in the form of better, more humane science.

• Our History
• Our Mission
• Evaluation Philosophy
• Fun Facts & Factoids
• NAGAP Visionary Award

IERF was established in 1969 as the first credentials evaluation service, not only in the U.S., but also in the world. IERF conducts research on international education and prepares credentials evaluations for persons who have studied outside of the United States and who need a statement of educational equivalency.

With over 54 years of experience, and having processed hundreds of thousands of evaluations, IERF is one of the most respected foreign credentials evaluation agencies in the U.S. IERF’s expertise is often sought for conference presentations and publications.

IERF has a multinational and multilingual team of experts, many of whom have studied outside the United States.

Our staff have a demonstrated knowledge of over twenty languages, including Afrikaans, Arabic, Armenian, Bemba, Belarussian, Cantonese Chinese, Catalan, Dutch, Farsi, Filipino, French, German, Hebrew, Italian, Japanese, Laotian, Mandarin Chinese, Portuguese, Russian, Slovak, Spanish, Taiwanese, Thai, and Ukrainian.

IERF is also a Founding Member of the National Association of Credential Evaluation Services (NACES®), a recognizing body for credentials evaluation services in the United States.

IERF was founded as a non-profit, public-benefit agency by Inez Sepmeyer and Ted Sharp, who were admissions officers at UCLA and California State University Northridge, respectively, and who recognized the need for assistance in the placement of international students and professionals.

Copyright © 2024 International Education Research Foundation, Inc.

Privacy Overview

International Research Foundation RSD/CRPS

turn your device to view this site correctly

• Special Reports
• Clinical Practice Guidelines
• Ketamine Therapy
• Live Opioid Conference
• Science Board

The International Research Foundation for RSD / CRPS is a not-for-profit organization (501c3) dedicated to education and research on Reflex Sympathetic Dystrophy and Complex Regional Pain Syndrome. The primary mission of the Foundation is to establish an international research network which will help educate medical professionals and support research worldwide. Reflex Sympathetic Dystrophy, known as RSD, is a chronic neurological disease which affects millions of people around the world. This disease is also known as Complex Regional Pain Syndrome or CRPS. The Foundation was the first to publish a study demonstrating the optimal dosing of ketamine required to treat CRPS. The website includes: Clinical Practice Guidelines for Reflex Sympathetic Dystrophy (Third Edition): The Clinical Practice Guidelines have become the guide for diagnosis and management of RSD / CRPS. Live International Video Conference: To learn about the use of opioids (narcotics) to treat CRPS in adults and children. 4K Video Tour: To learn more about our Headquarters and Surgery Center in Tampa, Florida USA --> 1910 East Busch Boulevard Tampa, Florida 33612 Website Developed by Rafztech

• ABOUT IMDTRF
• OUR MISSION
• BOARD OF DIRECTORS
• AWARDS BY YEAR
• CONTINUATION GRANT
• PETE WILDE SCHOLARSHIP

The International MDT Research Foundation is registered as a not-for-profit 501(c)(3) organization in the United States, operating on a worldwide basis under the governance of a Board of Directors. Applications for the Primary Grant will be accepted for the 2026 funding period until July 1st 2025. Before an application can be proceeded, a Letter of Intent has to be provided until April 1st 2025.

APPLY FOR A GRANT

Recent news.

International Retinal Research Foundation

Providing financial support for vision research. 

The International Retinal Research Foundation will be moving away from our Regular Grant Funding to concentrate on establishing collaborations and partnerships to maximize research impact.  All other funding, including Postdoctoral Scholars, will be supported.

Questions or request for information should be forwarded to Sandra Blackwood either by email, [email protected]   by phone,  205-325-8103 , or by writing to Sandra Blackwood, Executive Director, The International Retinal Research Foundation, Inc., 1720 University Blvd., Birmingham, AL 35233

Meet the new 2023 IRRF Scholar Awardees

  Rich Awardee   Kelman Awardee     Callahan Awardee  

The next submission date for IRRF Postdoctoral Scholar Awards is March 15. More Info . Download form: Grant Application.doc Questions or request for information should be forwarded to Sandra Blackwood either by email, [email protected] or phone, 205-325-8103

IRRF Continues a Partnership Initiative Providing Sustained Research Funding:

The International Retinal Research Foundation is continuing a partnership with The Retina Society that has provided research funding for two consecutive years, and will continue for one additional year. This partnership presents opportunities that leverage the power of matching grants from more than one source.

The Retina Society Research & Education Fund

Retina Society/IRRF Award

The main mission of the Retina Society is to advance knowledge and education in the field of retina.  Consistent with that mission, the Retina Society established a research and education grant program, with the objective of funding several annual research grants to support innovative research by Retina Society members.  In their inaugural year, two grants of $25,000 each were funded.  In 2022, The Retina Society and the IRRF partnered to fund three grants of $50,000 each per year for three years.

Eligibility:  Only active and associate members of The Retina Society may apply for grants.  For further information and funding guidelines, go to www.retinasociety.org .

2023 Retina Society/IRRF Awardees

In 2023, 13 grant applications across the spectrum of basic,

2022 Retina Society/IRRF Awardees

All grants were chosen for their scientific significance and rigor,

Current IRRF-Funded Research

The IRRF Board of Directors approves up to two years of funding for eight grantees. Below are the current awardees.

2023 Robert Machemer MD and International Retinal Research Foundation Fellowship

2023-RPB/IRRF Catalyst Award for Innovative Research Approaches for Age-Related Macular Degeneration (AMD)

Ubiquitylation of BBSome is required for ciliary assembly and signaling

Development of a Novel Technology to Connect Patients with Vision Loss: The Low Vision Connect App

Frontiers in Aging Neuroscience

Role of autophagy in photoreceptor cell homeostasis and disease.

2022 Robert Machemer MD and International Retinal Research Foundation Fellowship

Non-canonical roles of DNA damage signaling proteins in photoreceptor neuron morphogenesis and degeneration

Irrf featured news.

2023 IRRF/Macula Society Grantees

The International Retinal Research Foundation (IRRF) has partnered with The Macula Society to form The Macula Society/IRRF Award.  The Award is in accordance with the Macula Society’s purpose of providing

Charles DeBoer, MD, PhD Clinical Instructor, Ophthalmology The members of the Board of The Robert Machemer Foundation have awarded the 2023 Robert Machemer MD and International Retinal Research Foundation Fellowship

2023 Loris and David Rich Postdoctoral Scholar

Joel Jovanovic, PhD Vanderbilt University Medical Center, Department of Ophthalmology & Visual Sciences Nashville, Tennessee Project Title: The role of microglia-mediated inflammation on the cell fate of proliferating Müller glia

Search IRRF Archives

Latest events, the lasker/irrf initiative for innovation in vision science, convening of private vision research funding foundations, 2018 focus on eye health national summit.

• February 2024 (2)
• December 2023 (3)
• October 2023 (1)
• August 2023 (1)
• June 2023 (1)
• May 2023 (3)
• February 2023 (7)
• November 2022 (1)
• October 2022 (1)
• August 2022 (2)
• July 2022 (6)
• June 2022 (4)
• February 2022 (1)
• January 2022 (1)
• December 2021 (1)
• November 2021 (2)
• September 2021 (1)
• August 2021 (1)
• November 2020 (1)
• September 2020 (1)
• July 2020 (1)
• June 2020 (3)
• February 2020 (8)
• June 2019 (3)
• April 2019 (1)
• March 2019 (2)
• February 2019 (1)
• October 2018 (6)
• September 2018 (1)
• August 2018 (1)
• June 2018 (1)
• April 2018 (2)
• January 2018 (1)
• October 2017 (1)
• September 2017 (1)
• August 2017 (1)
• July 2017 (3)
• June 2017 (2)
• January 2017 (1)
• September 2016 (1)
• June 2016 (3)
• April 2016 (1)
• November 2015 (1)
• June 2015 (1)
• April 2015 (1)
• April 2014 (1)
• April 2013 (1)
• April 2012 (1)
• April 2011 (1)
• April 2010 (1)
• April 2009 (1)

Grant Application Forms Download

Postdoctoral Scholar Awards – $35,000 for One Year — Submission Deadline: March 15.

More Info . Download form: Grant Application.doc Questions or request for information should be forwarded to Sandra Blackwood either by email, [email protected] or phone, 205-325-8103

• News and Blogs
• Research and Publications
• Member Login
• What is IFRF?
• Meet the Team
• IFRF Council
• History of IFRF
• IFRF Activities
• History of TOTeMs
• National Committees
• Become a member
• Member Benefits
• IFRF Member Network
• Combustion Industry News
• Editorial Board
• Submit a paper
• Latest Papers & Archive
• European Facilities
• Current Projects

Subscribe to our FREE newsletter!

Every two weeks we share the latest combustion news, blogs and events in our newsletter 'Monday Night Mail'. Subscribe for FREE today and keep up to date.

Participate in EU-funded projects

We've brought together a list of relevant EU-funded projects our members might be interested in. Click here to read them all.

Industrial Combustion Journal

Submit your paper to the Industrial Combustion Journal and have it peer-reviewed and published by our Editorial Board

The International Flame Research Foundation – IFRF – is the research hub of the global industrial combustion community. We facilitate access to and disseminate research worldwide. Our mission is to advance combustion research and promote information transfer throughout the international combustion and energy arena.

Upcoming Events

Ifrf conference 2025 – sustainable and safe industrial combustion.

Sheffield, United Kingdom

17 - 19 Jun

Industrial Combustion training 18-19 March 2025

Les Loges-en-Josas, France

18 - 19 Mar

IFRF is the research and networking hub for the global combustion and energy community. Become an IFRF member today and connect with others from across the world including:

• End-users, designers and suppliers of fired heating equipment
• Process and system engineers and consultants
• Energy suppliers
• R&D/technology developers
• Universities and research institutes

Connect with us

Featured Research

Exhaust gas recycling for enhanced co2 capture: experimental and cfd studies on a micro-gas turbine.

Authors: Karen N Finney , Andrea De Santis , Thom Best , Alastair G Clements , Maria Elena Diego , Mohamed Pourkashanian

Published: October 2018

Submit a paper to the Industrial Combustion Journal

• Cookie Policy
• Accessibility

Members of the IFRF can have access to a range of exclusive benefits. To learn more about our membership options and what they currently offer click here .

Alternatively, to become a member fill out a form using the link below

• Become a Member
• Phone +44 114 222 3656
• Email [email protected]

Cookie Notice

This website uses cookies, including third party ones, to allow for analysis of how people use our website in order to improve your experience and our services. By continuing to use our website, you agree to the use of such cookies.

International Fellowships

Funding: $20,000–$50,000 Opens: September 3 Deadline: November 15

International Fellowships have been in existence since 1917. The program provides support for women pursuing full-time graduate or postdoctoral study in the United States to women who are not U.S. citizens or permanent residents, and who intend to return to their home country to pursue a professional career. A limited number of awards are available for study outside of the U.S. (excluding the applicant’s home country) to women who are members of Graduate Women International (see the list of GWI affiliates ). Both graduate and postgraduate studies at accredited U.S. institutions are supported.

Applicants must have earned the equivalent of a U.S. bachelor’s degree by the application deadline and must have applied to their proposed institutions of study by the time of the application. Recipients are selected for academic achievement and demonstrated commitment to women and girls.  

Recipients return to their home countries to become leaders in business, government, academia, community activism, and the arts or scientific fields.  

Award Amount

Master’s/first professional degree: $20,000 Doctoral: $25,000 Postdoctoral: $50,000

September 3, 2024 Application opens.

November 15, 2024, by 11:59 p.m. Pacific Standard Time Deadline for online submission of application, recommendations, and supporting documents.

April 15, 2025 Notification of decisions emailed to all applicants. AAUW is not able to honor requests for earlier notification.

July 1, 2025–June 30, 2026 Fellowship year

When a date falls on a weekend or holiday, the date will be observed on the following business day.

Eligibility

• International Fellowships are not open to previous recipients of any AAUW national fellowship or grant (not including branch or local awards or Community Action Grants).
• Members of the AAUW board of directors, committees, panels, task forces and staff, including current interns, are not eligible to apply for AAUW’s fellowships and grants. A person holding a current award is eligible for election or appointment to boards, committees, panels and task forces.
• International Fellowships are open to women, including people who identify as women, in all fields of study at an accredited institution of higher education or, for postdoctoral fellows, research. AAUW will make final decisions about what constitutes eligible institutions.
• Unsuccessful applicants may reapply.
• Have citizenship in a country other than the U.S. or possession of a nonimmigrant visa if residing in the U.S. Women who are currently, or expect to be during the fellowship year, a U.S. citizen, U.S. permanent resident, or dual citizen with the U.S. and another country are not eligible.
• Hold an academic degree (earned in the U.S. or abroad) equivalent to a U.S. bachelor’s degree completed by the application deadline .  
• Intend to devote themselves full-time to the proposed academic plan during the fellowship year.
• Intend to return to their home country to pursue a professional career upon completion of their studies.  
• Be proficient in English and confirm proficiency by submitting one of the Required Components (see below), which include certain English proficiency exams, transcripts from English-speaking institutions, or a written statement verifying English is the applicant’s native language. Applicants planning to take one of the accepted English proficiency exams should plan for and take the test as early as possible. Please direct questions about the tests to the test provider.
• Master’s/first professional degree and doctoral applicants must have applied by the AAUW application  deadline, to an accredited institution of study for the period of the fellowship year and must indicate the name of the institution in the International Fellowship application. While acceptance is not required at the time of application, fellows must provide official confirmation from the institution with their award acceptance materials.  
• Master’s/first professional degree fellowships are intended for master’s or professional degree-level programs such as J.D., M.F.A., L.L.M., M.Arch., or medical degrees such as M.D., D.D.S., etc. Certificates, associate degrees, and undergraduate degrees are ineligible.
• Doctoral fellowships are intended for doctorate degrees classified as research degrees, such as Ph.D. or Ed.D.
• Postdoctoral applicants must provide proof of their doctorate degree; hold a doctorate classified as a research degree (e.g., Ph.D., Ed.D ., D.B.A., D.M .) or an M.F.A. by the application deadline ; and indicate where they will conduct their research.  
• Master’s/first professional degree and doctoral applicants must be enrolled in a U.S.-accredited institution located in the U.S. during the fellowship year.  
• A limited number of awards are available to Graduate Women International members for study or research in any country other than their own. Note that foreign branches of U.S. institutions are considered outside of the U.S.
• Applicants can apply for the fellowship for any year of their program but must be conducting a full year of study or research. International Fellowships do not provide funding for a partial year of study or research. Programs ending prior to April of the fellowship year are not eligible.
• Distance learning/online programs: Master’s/first professional degree and doctoral fellowships support traditional classroom-based courses of study at colleges or universities. This fellowship program does not provide funding for distance-learning or online programs or for degrees heavily dependent on distance-learning components. Final decisions about what constitutes distance learning under these fellowships will be made by AAUW. AAUW will accept applications from applicants who are temporarily studying remotely due to COVID-19 precautions at their institution.

Criteria for Selection and Application Review

The panel meets once a year to review applications for funding. Awards are based on the criteria outlined here. Recommendations by the panel are subject to final approval by AAUW. Fellowships are awarded on a competitive basis according to funds available in a given fiscal year.

To ensure a fair review process, AAUW does not comment on the deliberations of its award panels. AAUW does not provide evaluations of applications. No provisions exist for the reconsideration of fellowship proposals. Applications and supporting documents become the sole property of AAUW and will neither be returned nor held for another year.  

• Applicants residing in their home country at the time of application, from developing/emerging countries, or from an underrepresented group in any region, will receive special consideration.
• Position on return to home country.
• Academic and/or professional qualifications.
• Demonstrated commitment to the advancement of women and girls in home country.
• Proposed time schedule.
• Quality and feasibility of proposed plan of study or research.
• Demonstrated evidence of prior community and/or civic service in home country.
• Applicant’s country’s need for specialized knowledge or skill.
• Financial need.
• Motivation for graduate study or research.

Regulations

International Fellowship funds are available for:

• Educational expenses.
• Living expenses.   Dependent child care.  
• Travel to professional meetings, conferences, or seminars that do not exceed 10% of the fellowship total.  

International Fellowship funds are not available for:

• Purchase of equipment.  
• Indirect costs.  
• Research assistants.  
• Previous expenditures, deficits, or repayment of loans.  
• Publication costs.  
• Institutional (overhead) costs.
• Tuition for dependent’s education.  
• Grants-in-aid for less than a full academic year or travel grants.  
• Travel to or from a fellow’s home country.  
• Travel to or from the fellow’s research location, if abroad (does not apply to fellows who are GWI members with AAUW approval to study or research in a country other than their own).    

AAUW regards the acceptance of a fellowship as a contract requiring the fulfillment of the following terms:

• All International Fellowship recipients are required to sign a contract as an acceptance of the award. Retain these instructions as they will become part of the fellowship contract if the applicant is awarded a fellowship.  
• An International Fellow is expected to pursue their project full-time during the fellowship year (July 1–June 30). No partial fellowships are awarded. Fellowships may not be deferred.
• Any changes in plans for the fellowship year must have the prior written approval of AAUW. AAUW must be notified promptly of any change in the status of an application resulting from the acceptance of another award.  
• Fellows may spend up to two months traveling abroad for research related to their project plan with prior written approval of AAUW.
• Postdoctoral fellows cannot pursue a degree during the fellowship year.
• Up to five International Master’s/First Professional Degree Fellowships are renewable for a second year. Fellows will receive application information for this competitive program during their fellowship year.
• Stipends are made payable to fellows, not to institutions.
• With some exceptions based on relevant tax statuses and treaties, the fellowship stipend is subject to a 14 or 30 percent tax. AAUW will withhold these funds for payment to the Internal Revenue Service.
• The determination of whether there is a tax obligation associated with the receipt of an AAUW award is the sole responsibility of the applicant. Specific questions regarding income tax matters should be addressed with the U.S. Internal Revenue Service, the applicant’s financial aid office or a personal tax adviser. AAUW cannot provide tax advice. AAUW is a nonprofit, tax-exempt 501(c)(3) public charity founded for educational purposes.
• Responsibility for securing visas and other documents , and following policies associated with visas, rests solely with the fellow.  

Required Components*

Start the application process by clicking the Apply Now button below to access the application and create an account through our vendor site. Complete all required components in the following areas.

• Provide two recommendations from professors or professional colleagues well acquainted with the applicant, their work, and their academic background, in striving towards scholarly pursuits. When possible, recommenders should be professors or professional colleagues in the applicant’s home country who can speak about the applicant’s qualifications and about the country’s need for the specialized skill or knowledge they plan to acquire with their proposed study or research. AAUW does not accept references from dossier services, such as Parment or Interfolio.
• Transcripts** must include a list of courses taken and grades received.
• If the institution does not provide a transcript or a list of courses taken and grades received or the degree did not require coursework, an official letter from the institution where the degree was received that includes the degree completion date must be uploaded.
• Do not upload copies of additional certificates or other documents the applicant may have received during their education.
• Transcripts must include a list of courses taken and grades received.
• Many transcripts do not include current coursework. If fall 2023 semester grades are not available and are not on your transcript, a list of courses taken that semester must be provided by the institution’s Office of the Registrar.
• If the institution does not provide a transcript or a list of courses taken and grades received or the degree did not require coursework, an official letter* from the institution where the degree was received that includes the degree completion date must be uploaded.
• Transcript showing degree and date received (must be on or before application deadline ).  
• Official letter from institution where degree was received that includes the degree completion date.
• Copy of diploma showing date degree was received (must be on or before application deadline ).  
• TOEFL iBT (Internet-Based Test): 79
• TOEFL Essentials: 8.5
• Revised TOEFL Paper-Delivered Test: 60
• Cambridge Assessment: 176  
• Written statement verifying the applicant’s native language is English.
• Secondary diploma or undergraduate degree is from an English-speaking institution.
• One semester of full-time study in the applicant’s discipline at an English-speaking institution between November 202 1 and November 202 3.

*A certified English translation is required for all components provided in a foreign language. Translations must bear a mark of certification or official signature that the translation is true and complete.

**All transcripts provided must include the applicant’s full name, the school’s name, all courses, and all grades, as well as any other information requested in the application instructions.

See More Fellowship and Grant Opportunities

For questions or technical support from ISTS, our technical consultant, please email [email protected] . Enter AAUW-IF if the website prompts you for a program key. We encourage applicants not to opt out of communications from ISTS, to ensure you receive important communications from AAUW.

Thanks to AAUW’s International Fellowship (1992-93), I graduated Harvard Kennedy School … then joined the UN working for democracy and gender equality. I really want to thank you.” Mikiko Sawanishi, deputy executive head, United Nations Democracy Fund and 1992-3 International Fellow

Meet a Recent International Fellow

Alexandra Semma Tamayo has worked as a forensic anthropologist at the Institute of Legal Medicine and Forensic Sciences in Villavicencio, Colombia. Her multidisciplinary approach to the identification of missing persons from enforced disappearance has helped bring justice to the families in armed conflict contexts. As an international fellow, her research in fracture patterns observed in gunshot wounds will be extremely helpful in improving the accuracy in trauma interpretation when working with human-rights violations.

Meet Our Alumnae

Tererai Trent

2001–02 International Fellow and scholar, motivational speaker and humanitarian. She founded Tererai Trent International, whose mission is to provide quality education in rural Africa. Oprah Winfrey named Trent as her all-time favorite guest. In 2017, Trent received the AAUW Alumnae Recognition Award.

Mahnaz Rezaie

2014–16 International Fellow and photojournalist, filmmaker and writer who advocates for the rights of Afghan women. She was honored at the 2014 Women in the World Summit for her short film exploring how wearing a hijab in the U.S. affected her relationships.

Sofia Espinoza Sanchez

2013–14 International Fellow and Peruvian molecular biochemist researching cancer and neurological disorders. She also co-directs the Research Experience for Peruvian Undergraduates program.

Subscribe to our newsletter

You must enable JavaScript to sign up.

• Follow University of Limerick on Facebook
• Follow University of Limerick on X/Twitter
• Follow University of Limerick on Instagram
• Follow University of Limerick on LinkedIn
• Follow University of Limerick on YouTube
• Follow University of Limerick on TikTok
• Search University of Limerick website

International business award success for two Lero members

Two members of Lero, the Science Foundation Ireland Research Centre for Software, headquartered at University of Limerick, have won International Business Awards.

Known as ‘the International Stevies’, the International Business Awards® are open to all organisations worldwide.

This year, more than 3,600 nominations from organisations of all sizes across 62 nations were submitted for consideration in a wide range of categories.

Nicola Corless, Communications and Marketing Manager at Lero, was named the winner of a Silver Stevie Award in the Communications Professional of the Year category while Professor Martin Glavin, Lero Funded Investigator, was awarded a Bronze Stevie in the Thought Leader of The Year - Government or Non-Profit category the 21st annual International Business Awards.

Nicola is based at University of Limerick and Martin is Head of Electrical and Electronic Engineering at University of Galway.

Winners were determined by the average scores of more than 300 executives worldwide who participated in the judging process in June and July.

Judges commended Nicola for her “exceptional skills and dedication” with one judge noting "her significant contributions to Lero, demonstrating her strategic impact, innovative approach, and measurable successes in enhancing the organisation's media presence and engagement”.

According to another member of the judging committee, “Professor Martin Glavin stands out as a deserving candidate for the Thought Leader of the Year - Government or Non-Profit award due to his significant contributions to public discourse on road safety and technology. Beyond his extensive academic publishing and teaching, Prof. Glavin has demonstrated a robust commitment to engaging with the wider public and policymakers”.

Lero is a previous winner at the International Business Awards having won a Silver for its re-brand at last year’s awards, while Nicola previously won Gold and a Silver for her public relations work with University of Limerick in 2017. 

“Lero has built an outstanding reputation over the years and our members are key pillars of that. Both Nicola and Martin are leaders in their fields who continue to be invaluable to Lero and winning these internationally recognised awards showcases this,” said Lero Director Professor Lionel Briand.

NSFC Headlines News Updates

Nsfc constitution nsfc regulations, nsfc annual report international evaluation report synthesis evidence report for international evaluation -->, introduction partnerships categories the research fund for international scientists science fund for global challenges and sustainability, application and review process guide to programs, nsfc at a glance organization contact us nsfc leadership, national natural science foundation of china and the european organization for nuclear research (nsfc-cern) large scientific infrastructure international cooperation research program 2024 call for proposals.

The European Organization for Nuclear Research (CERN) is a leading international organization for cutting-edge research at the forefront of particle physics, hosting the Large Hadron Collider (LHC), the world's highest-energy hadron collider. The four large detector experiments (ALICE, ATLAS, CMS, and LHCb) leverage the most advanced detection technologies to capture and study microscopic phenomena, providing a premier platform for the development of advanced particle detection technologies. CERN, which brings together more than 12,000 researchers from over 70 countries, has become a prime example of international cooperation. Since 1997, the National Natural Science Foundation of China (NSFC) has been supporting Chinese researchers to participate in these significant LHC experiments. In 2024, NSFC sets up the "NSFC-CERN Large Scientific Infrastructure International Cooperation Research Program", following the organizing mechanism of the NSFC Major Research Plan program. The program, with a special focus on detector upgrades and physical research, provides different levels of funding through cultivation projects, key projects, integration projects, etc. This program aims to provide sustainable support to Chinese teams to participate in the international cooperative research at CERN, and contribute to the scientific innovation, technological development, talent cultivation, and international cooperation in the fields of particle physics and nuclear physics.

I. Scientific Objectives

This program is dedicated to developing advanced particle detection technologies for the four large detector experiments (ALICE, ATLAS, CMS, and LHCb) on the CERN LHC and promoting cutting-edge research in particle and nuclear physics. The goals include: to precisely measure the properties of the Higgs boson to understand the origin of mass of elementary particles; to accurately test the Standard Model of particle physics, search for new physics beyond the Standard Model, and understand the asymmetry between matter and antimatter in the universe; and to gain a deeper understanding of the non-perturbative aspects of quantum chromodynamics, the phase transitions, and new states of strongly interacting matter.

II. Core Scientific Issues

1. Precise measurement of the Standard Model and the properties of the Higgs boson.

2. New physics beyond the Standard Model and the mechanisms of charge-parity (CP) symmetry breaking.

3. The essence of strong interactions and the internal structure of hadrons.

4. Properties of quark-gluon plasma under extreme conditions of high temperature, high density, and low chemical potential.

5. Advanced particle detectors and key detection technologies.

III. Project Settings and Funding Areas for 2024

1. Detector Upgrade Projects:

1) Key projects for the CMS experiment detector upgrade, including the development of the GEM detector for the muon spectrometer upgrade and the crystal time-of-flight detectors for the minimum ionizing time detector upgrade in the barrel section.

2) Integration projects for the CMS experiment detector upgrade, involving the utilization of large-area radiation-resistant silicon sensors to develop high-granularity calorimeters capable of detecting energy, timing, and three-dimensional position.

3) Key projects for the LHCb experiment detector upgrade, targeting the upstream tracker upgrade in the LHCb magnetic field and preliminary research on high-voltage CMOS chip design based on advanced manufacturing processes. Development of software and algorithms for the electromagnetic calorimeter upgrade and simulation studies of its performance and key physical processes.

4) Key projects for the ALICE experiment detector upgrade, focusing on the development of high time-resolution Time-of-Flight detectors using Low-Gain Avalanche Detector (LGAD) technology to meet the requirements of the ALICE 3 upgrade project.

5) Integration projects for the ATLAS experiment detector upgrade, focusing on the development of resistive chamber plate RPC detectors for the muon spectrometer upgrade and silicon microstrip ITK-strip detectors for the inner tracker upgrade.

2. Physical Research Projects:

1) Cultivation projects for conducting cutting-edge physics research related to final states involving muons and the study of muon spectrometer performance in the ATLAS Experiment at LHC Run-3.

IV. Basic Principles for Project Selection

To ensure the achievement of the overall objectives, this program encourages:

1. Technical research and development of key detectors closely related to the overall objectives.

2. Physical research closely related to the overall objectives.

3. Research with international impact that aligns with the development of international cooperation.

4. Original and innovative research ideas and exploratory studies with unique features.

V. Funding Plan for 2024

1. About one cultivation project is to be funded. NSFC budget is up to 600,000 RMB per project (direct costs) for a duration of 3 years, from January 1, 2025 to December 31, 2027.

2. About five key projects are to be funded. NSFC budget is up to 3 million RMB per project (direct costs) for a duration of 4 years, from January 1, 2025 to December 31, 2028.

3. About three integration projects are to be funded. NSFC budget is up to 7.5 million RMB per project (direct costs) for a duration of 4 years, from January 1, 2025 to December 31, 2028.

VI. Application Requirements and Notices

1. Eligibility Criteria:

1) Applicants must have experience in undertaking basic research projects.

2) Applicants must hold senior academic ranks (titles).

3) Postdoctoral researchers, individuals currently pursuing graduate degrees, and individuals without an affiliation or whose affiliation is not a NSFC host institution are not eligible to apply.

2. Limits of Parallel Application:

1) As the Principal Investigator, an applicant shall not apply for more than one project to this program in the same year.

2) The total number of NSFC projects that researchers with senior academic ranks (or titles) can apply for or undertake (as the PI or major participants) is limited to two projects. Applications for cultivation projects and key projects shall be counted within the number limits, while applications for integration projects are not counted within the number limits.

3) More requirements can be found in the NSFC 2024 Guide to Programs .

3. Application Requirements:

Applicants and their host institutions shall carefully read and follow the guidelines provided in this call text, the NSFC 2024 Guide to Programs , and the Notice on the Application and Completion of NSFC Projects in 2024 .

1. No hard copy of the application is needed. Applications must be submitted electronically between September 29, 2024, and October 10, 2024, by 16:00.

1) Applicants shall submit a completed online application to the NSFC’s Grants System (http://grants.nsfc.gov.cn). The procedure is to log into the Grants System as the PI, click the “online submission” button, then click the “new application” button, select "Science Fund for Global Challenges and Sustainability (面向全球的科学研究基金项目)”, and then "Large Scientific Infrastructure (CERN)（重大科学基础设施（CERN））"， and choose one project type from "Cultivation Project-Physical Research （培育项目-物理研究）", "Key Project-Detector Upgrade (重点支持项目-探测器研制)," or "Integration Project-Detector Upgrade (集成项目-探测器研制)," based on the specific research content of the application.

2) The number of collaborative institutions for cultivation projects and key projects shall not exceed two, and for integration projects, shall not exceed four.

3) Applicants should independently formulate the project titles, scientific objectives, research content, technical route, and corresponding budget based on the core scientific issues and funding areas of this program. Physical research projects should take an interdisciplinary approach and make significant contributions to the core scientific issues and the overall objectives of the program. Applications that do not meet the requirements will not be accepted.

4) Applicants shall complete and submit electronic application forms and attachment materials online according to the instructions and outlines provided in the NSFC’s Grants System. The main part of the application shall be written in English. Applications that do not meet the requirements will not be accepted.

5) For detector upgrade projects, applicants must submit a certificate of collaborative research signed by the spokespersons of the respective experiments of CERN using the attached template. Applications that do not meet the requirements will not be accepted.

6) Applicants must submit the English CVs of the applicant and major participants in the attachments.

2. The host institutions should verify each item of the electronic application package via NSFC’s Grants System and submit all proposals and supplementary documents to NSFC before 16:00 on October 10, 2024. Late applications will not be accepted. The host institutions should upload a list of all the applications within 24 hours after the application deadline.

3. To monitor the progress of the projects and promote coherent research activities, the Steering Committee and Working Group of the program will organize annual meetings of the funded projects or regular workshops to facilitate communication and coordination. The PIs should participate in such workshops/meetings and make a budget for relevant costs, and are also responsible for coordinating their international research partners to participate in such activities.

4. Contact Information

Division III, Department of International Programs:

· Wu Congcong, Li Wencong

· Tel: 010-62325143, 62327014

· Email: [email protected], [email protected]

NSFC Grants System technical support:

· Tel: +86-10-6231 7474

· Template of the certificate of collaborative research

National Natural Science Foundation of China

Add: 83 Shuangqing Rd., Haidian District, Beijing, China

Postcode: 100085

Tel: 86-10-62327001

Fax: 86-10-62327004

E-mail: [email protected]

京ICP备05002826号 文保网安备1101080035号 Copyright 2017 NSFC, All Right Reserved

The Skolkovo Foundation: fostering innovation and entrepreneurship in the Russian Federation

By Igor Drozdov , Chairperson of the Skolkovo Foundation, Moscow, Russian Federation

This year marks the tenth anniversary of the creation of the Skolkovo Innovation Center, a landmark initiative designed to create a sustainable innovation ecosystem and foster a culture of entrepreneurship to support the development and commercialization of advanced technologies in the Russian Federation and beyond.

Under the oversight of the Skolkovo Foundation, also established in 2010, the purpose-built high-tech innovation area in Skolkovo has become the country’s leading innovation hub. Its fully integrated and vibrant innovation ecosystem comprises a broad range of facilities and services to support innovation and entrepreneurship in the fields of information technology, biomedicine, energy, nuclear technologies and space technologies.

Europe’s largest Technopark set to expand

Skolkovo’s Technopark is the largest in Europe. Covering an area of some 100,000 square meters, it offers resident companies modern office space, including coworking arrangements, as well as laboratories equipped for rapid prototyping and testing of new technological developments.

In little over a year of its construction, the Technopark was completely filled with startups. It now houses over 400 companies operating in a wide range of technology sectors: from private space travel ventures to precision agriculture and digital medicine.

In response to demand, plans are in view to expand the Technopark site; the space available for startups will practically double within five years. Importantly, companies wishing to benefit from the Skolkovo’s facilities do not have to be physically located within the Technopark itself. Research teams simply need to submit an application and an outline of their research project via the Skolkovo website. Once their project is approved by a panel of independent experts with specialist knowledge in their area of work, they will gain Skolkovo resident status. In this way, international teams willing to work in the Russian Federation, and to set up a business under Russian law, may apply for residency at the Skolkovo Innovation Center.

Every day, the Skolkovo Foundation receives around ten residency applications. While they don’t all make it through the review process, on average, 500 new residents join the Skolkovo Innovation Center every year. At present, close to 2,500 companies, including subsidiaries of foreign companies located in practically all regions of the country, hold Skolkovo residency status.

Residents of the Skolkovo Technopark enjoy significant benefits both in terms of earnings and business growth. In 2019, for example, the total earnings of Skolkovo Technopark residents exceeded USD 1.5 billion, representing a year-on-year increase of more than 40 percent.

Medical tech is booming

Many companies with Skolkovo residency status have become global leaders in their field of technology. Medical biotech, a particularly vibrant area of activity, continues to witness the greatest demand for patent rights. The value of a patent for a molecule can reach tens of millions of dollars. In 2019, over one hundred of the patents granted by IP offices outside the Russian Federation – more than half of all such patent applications – were granted to Skolkovo residents for medical technology solutions.

Examples of innovative medical tech companies include Hepatera, which developed the world’s first drug to treat hepatitis D, a previously untreatable illness. The company’s drug, Myrcludex, was registered in the Russian Federation in late 2019 and in the European Union in 2020 and has been designated a “breakthrough therapy” by the United States Food and Drug Administration (USFDA).

Similarly, the biotech company Viriom has developed a drug to treat patients with the human immunodeficiency virus (HIV); the drug was registered in Russia in 2017. The company is currently working on improving the drug’s formula with the aim of reducing dosage frequency.  A new version of the drug is expected by 2022.

Expertise in other advanced technologies

Skolkovo startups are also successful in other spheres of technology. Take for example, CRT‑Innovations, one of the world’s leading developers of innovative speech synthesis and recognition technology systems. The company’s technologies are used in 75 countries. Under a contract with the Mexican government, CRT-Innovations created the first nationwide voice identification system in the world.

Similarly, quantum communications experts at T8 are developing telecommunications equipment for optical communications networks. In terms of its economic and technical features, T8 rivals global leaders like Huawei and Nokia. The company’s share in the Russian market is currently around 20 percent.

In the area of space technology, Sputnix is the first private Russian company to put a microsatellite into orbit and has plans to launch seven microsatellites in 2020, including on behalf of companies from Tunisia and Saudi Arabia.

And in the area of additive manufacturing, AMT is a world leader in 3-D printing for construction. A printer developed by the company created Europe’s largest 3-D printed residential building – a fully-fledge house in the Russian city of Yaroslavl – using this technology.

These are just a few examples of the long list of groundbreaking achievements of startups emerging from Skolkovo. Around 250 of them have already entered foreign markets.

Skolkovo makes headway in building a culture of intellectual property (IP)

As a general rule, patent protection is key to attracting investors and boosting sales, and enabling business growth when a company enters a new market, whether at home or abroad.

Unfortunately, however, Russian companies have some way to go in terms of securing patent protection in markets beyond the Russian Federation. Data for 2019 show that applicants from the Russian Federation filed just 1,102 international applications under the Patent Cooperation Treaty (PCT) administered by the World Intellectual Property Organization (WIPO). Of these, 159 international applications (14.5 percent) were filed by companies connected with the Skolkovo ecosystem. In 2019, Skolkovo startups were granted 205 foreign patents, of which 35 percent were granted by patent offices in Western European countries and the United States. That’s a pretty good result!

Many of the technologies developed by Skolkovo startups have already gone into mass production and are market leaders in Russia.

Cooperation with industrial partners

In general, cooperation with major industrial partners is an important factor in a startup’s success. That is why the Skolkovo Foundation facilitates links between Skolkovo startups and major companies, with a view to making it possible for startups to scale up their technologies in those companies. This is an important area of our work, as it is the only way, in practical terms, that startup technologies can have a substantial impact on the economy and everyday life.

Many of the technologies developed by Skolkovo startups have already gone into mass production and are market leaders in Russia, in particular, in the areas of the Industrial Internet of Things, banking security and remote banking, and waste disposal and recycling.

Major international companies join Skolkovo’s innovation scene

Many major companies have also opened their own research centers on the grounds of the Skolkovo Innovation Center. Such companies include Boeing, Enel, Huawei, Hyundai, Koninklijke Philips, Nokia, Orange Business Services, Panasonic, Syngenta, and Telnet, among others. These research centers are enriching innovative activity at Skolkovo by helping to create a favorable environment and a concentration of intellectual capital. These are important factors in creating the conditions for scientific research and business collaboration to take off.

Skoltech: promoting science, technology and entrepreneurship

The Skolkovo campus also includes the Skolkovo Institute of Science and Technology (Skoltech). Established less than ten years ago, Skoltech offers a range of master’s degree and other post-graduate programs.

From the very outset, Skoltech brought education, science and entrepreneurial activity under one roof. Instruction at Skoltech is conducted exclusively in English and is currently free of charge, making it possible for talented students from across the globe to study at the Institute.

At present, around 1,100 students are enrolled at Skoltech. Foreign students account for more than 20 percent of the student population. The majority of the students at Skoltech are mature young people who have decided to devote their lives to science and technological entrepreneurship. Around 40 percent of enrolled students are following post-graduate programs.

Skoltech also employs close to 200 professors of which some 30 percent are from other countries. Another 30 percent are Russian nationals who, having spent 10 or 20 years abroad, have returned to work in Russia and at Skoltech, in particular.

Skoltech hosts more than 20 scientific centers and laboratories. All of the Institute’s professors and students engaged in educational programs are also employees of those centers. Many of the centers work with industry and a number of industrial laboratories have been created jointly with foreign companies, including Huawei and Oerlikon.

Commercializing scientific knowledge: a priority

Creating an effective system for the commercialization of scientific knowledge is also a priority for Skoltech’s professors and students. Around 70 companies that have been spun out from Skoltech have become residents of Skolkovo’s Technopark.

Over the past two years, Skolkovo startups as a whole have attracted annual investments of around USD 200 million.

Last year, Skoltech was the only University in the Russian Federation to feature among the Nature Index 2019’s top 100 young universities. In terms of the number of journal publications per professor, Skoltech is on a par with the top three young universities in the 2019 Nature Index ranking, namely, Nanjing Technology University (China), Hong Kong University of Science and Technology (Hong Kong SAR), and the Korean Institute of Advanced Technologies (Republic of Korea).

Facilitating access to investment

Investors are a further priority for the Skolkovo Innovation campus. The appetite among investors to plough funds into high-tech startups in the Russian Federation remains low. However, over the past two years, Skolkovo startups as a whole have attracted annual investments of around USD 200 million.

While the investment trend is moving in a positive direction, the Skolkovo Foundation recognizes that there is still great scope for improvement. That is why the Foundation is actively working with venture capital funds and business angels to boost the investment environment for Skolkovo startups. The Foundation also offers mentoring and other business incubation services to support the development of Skolkovo startups and enable them to pitch their work effectively to Russian and foreign investors. 

IP and Skolkovo’s Intellectual Property Center

The emergence of new technologies inevitably raises questions relating to IP; first, in terms of protecting those technologies with IP rights, including patents; and second, with respect to mergers and takeovers, which typically involve the exchange of valuable business holdings, including IP assets.

IP is a startup’s most valuable asset, particularly in the early stages of its development. That is why it is so important to ensure that the startup has in place an effective IP strategy that supports its business development goals. Recognizing the crucial importance of advising and supporting startups on matters relating to IP, one of the Foundation’s first actions was to create the Intellectual Property Center.

Our ambition is for the Skolkovo model to be replicated across the Russian Federation and beyond and for our campus to become a magnet for talent from around the world.

The Center’s patenting services are now available to Skolkovo residents under market conditions, although some of the associated costs may be recovered, at least in part, through various grant programs.

Patents obtained by Skolkovo residents with the help of Skolkovo IP Center’s patent attorneys are regularly included among the top 100 best inventions in Russia and are ranked highly at international exhibitions.

The Center is one of the leading providers of patent services in the Russian Federation. The number of international patent applications filed under the PCT by the Skolkovo IP Center on behalf of Skolkovo residents, or companies with a connection to Skolkovo, account for around 14.5 percent of all such applications filed by applicants from the Russian Federation.

The Skolkovo Foundation works closely with WIPO. Indeed, the WIPO Russian Office, the only WIPO External Office in Eastern Europe, is located on the grounds of the Skolkovo Innovation Center. Each year, Skolkovo and WIPO co-organize the IP Academy, the largest educational conference on IP in the region, bringing together more than a thousand participants from across Russia and neighboring countries.

Shaping national IP legislation for the future

At the national level, the Skolkovo Foundation plays a significant role in drafting and advancing amendments to IP legislation. Technological developments are outpacing legislative changes at a rapid rate. New phenomena require clarification of legal terminology and the regulation of new social relationships and business models.

In addressing these issues, the Foundation has contributed to draft laws that seek to better regulate the registration and sale of computer programs and relations among co-owners of IP rights. It has also been examining the possibility of using blockchain technology to register and record IP rights. The Foundation also contributed directly to the drafting of a law on regulatory sandboxes – experimental legal regimes for drones, telemedicine, etc. That law was adopted by the Russian Parliament at its first reading and it is foreseen that such experimental legal regimes will be established at Skolkovo in the near future.

Artificial intelligence and big data

In recent years, major technological advances within the information technology sector have given rise to broad discussions, including at the international level , on the impact of artificial intelligence technologies and big data processing on IP policy and practice. The Skolkovo Foundation stands ready to work with WIPO and the international IP community to develop best practices and common approaches to ensure that the IP system continues to serve as an effective incentive mechanism to foster innovation and creativity in the digital environment.

While much has been accomplished over the last decade, there is still a great deal to achieve. The Foundation is already implementing the large-scale expansion of the Skolkovo campus to further strengthen this dynamic innovation ecosystem. Over the next five to seven years, we anticipate a four-fold increase in the number of Skolkovo residents. We also expect two major technology companies, Sberbank, a state-owned Russian banking and financial services company, and Yandex, the Russian-owned technology company, and the country’s leading web search engine, to build large campuses at Skolkovo.

Our ambition is for the Skolkovo model to be replicated across the Russian Federation and beyond and for our campus to become a magnet for talent from around the world. That will be our focus over the next decade.

The WIPO Magazine is intended to help broaden public understanding of intellectual property and of WIPO’s work, and is not an official document of WIPO. The designations employed and the presentation of material throughout this publication do not imply the expression of any opinion whatsoever on the part of WIPO concerning the legal status of any country, territory or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. This publication is not intended to reflect the views of the Member States or the WIPO Secretariat. The mention of specific companies or products of manufacturers does not imply that they are endorsed or recommended by WIPO in preference to others of a similar nature that are not mentioned.

• Send a comment on this article
• Back to Contents page

Research could lead to potentially revolutionary advancements in hemorrhagic stroke treatment.

Sept. 5, 2024

— Credit: Getty Images/peterschreiber.media

A transformative $25.9 million grant from The Marcus Foundation will accelerate pioneering research aimed at revolutionizing hemorrhagic stroke treatment.  This major award will fund the Rapid Evacuation and Access of Cerebral Hemorrhage (REACH) trial and its companion REACH registry, led by Emory University School of Medicine and Grady Health System’s Marcus Stroke and Neuroscience Center.

The REACH trial will explore treatment for intracerebral hemorrhage (ICH), a severe form of hemorrhagic stroke where bleeding from a ruptured vessel occurs directly within the brain tissue, causing severe damage to brain cells and disrupting vital brain functions. Affecting approximately 3.4 million people globally each year, these strokes are the deadliest and most debilitating, with significant health and economic impacts. Despite medical advancements, current treatment options are limited, especially for deep ICH.

Building on the success of the national ENRICH trial , which demonstrated the effectiveness of minimally invasive parafascicular sugery (MIPS) for ICH in the brain’s lobar region, and published in April 2024 in the New England Journal of Medicine, the REACH trial seeks to further these advancements. This ambitious study will be the first to investigate the use of MIPS for deep ICH, particularly within the anterior basal ganglia, a challenging and more commonly affected area.

Gustavo Pradilla, MD, a leading neurosurgeon at Emory University and Grady Health System, emphasizes the significance of the REACH trial. “This initiative represents a significant step forward to advance hemorrhagic stroke treatment. By refining the MIPS technique and expanding its use to the basal ganglia, we aim to transform the standard of care for patients with spontaneous ICH, improving outcomes and reducing the devastating impact of this condition.”

Pradilla, co-principal investigator for REACH, is a professor of neurosurgery at Emory University School of Medicine and chief of neurosurgery at Grady Health System.

According to Pradilla, there is currently no proven standard of care for surgically treating ICH in the basal ganglia, as no clinical trial has demonstrated the effectiveness of such interventions.

While MIPS represents a paradigm shift for ICH in the lobar region, closer to the brain’s surface - as established in the ENRICH trial - medical management remains the approach for deeper hemorrhages, since conventional surgery prevents death but does not improve long-term disability outcomes.  

The REACH trial will enroll approximately 600 patients at up to 60 stroke centers nationwide over four years, with enrollment targeted to begin in December 2024. MIPS offers a less invasive alternative, using advanced computerized brain mapping and small instruments to remove clots and control bleeding. The procedure requires a smaller opening in the skull than a conventional craniotomy and allows for higher rates of clot removal and control of the bleeding source without damaging surrounding tissue.

In addition to optimizing the MIPS technique and demonstrating its safety and efficacy, REACH will establish new guidelines for treating patients with ICH in the brain’s basal ganglia. The accompanying REACH registry will build a comprehensive data repository, guiding future clinical practices and promoting broader adoption of MIPS for patients with spontaneous ICH.

Like ENRICH, the REACH trial will utilize FDA-cleared technology to access and evacuate the hematoma and a standardized approach in additional to guideline-based medical management.

Stroke remains a significant public health issue, with up to 50% of hemorrhagic stroke patients dying within 30 days and only 25% of survivors regaining full independence. The financial burden is equally severe, costing the U.S. health care system approximately $17 billion annually, with $12 billion attributed to care and productivity losses for survivors.

Since 2008, The Marcus Foundation has awarded more than $72 million to the Emory/Grady team to advance stroke research, prevention and treatment. Their initial grant was instrumental in establishing thrombectomy as a key treatment for mechanical removal of blood clots in the brain. 

“This grant, believed to be the largest philanthropic award ever made for clinical research targeting fatal stroke intervention, underscores the long-standing partnership and commitment of The Marcus Foundation in supporting lifesaving stroke research. Their continued investment has been crucial in driving breakthroughs that offer new hope to patients,” says Michael Frankel, MD, chief of neurology and director of the  Marcus Stroke and Neuroscience Center  for Grady Health System. He is also a professor of neurology and division director of vascular neurology at Emory University School of Medicine.

“After witnessing the staggering death and disability strokes cause, I knew we had to do more to discover new treatment options,” says Bernie Marcus, founder of The Marcus Foundation and co-founder of The Home Depot. “Breakthroughs like this new approach for the deadliest form of stroke and others made by the stellar team at the Marcus Stroke & Neuroscience Center will save and change lives around the world for decades. That's a remarkable philanthropic return on investment.”

In addition to Pradilla, the REACH trial principal investigators include Jonathan Ratcliff , MD, MPH, associate professor of emergency medicine at Emory University School of Medicine and director of neurocritical care at Grady Health System, and Alex Hall , DHSc, MS, assistant professor of emergency medicine and director of clinical trials at the Emory Neurosciences Lab and Trial Operations Core, Emory University School of Medicine.

“We are profoundly grateful to The Marcus Foundation for this monumental award, which reaffirms the power of collaborative, visionary support in addressing one of the world’s most critical health challenges. REACH has the potential to significantly improve treatment options for stroke patients, both in Georgia, where stroke remains a leading cause of death, and far beyond,” says Ravi Thadhani, MD, MPH, executive vice president for health affairs at Emory University.

Pivotal stroke research led by the Emory/Grady team  

NINDS tPA Stroke Trial: Clinical trial that changed the standard of care for patients with acute ischemic stroke establishing the benefit of the intravenous clot busting medication called tissue plasminogen activator (tPA). Published in New England Journal of Medicine in 1995 and 1999 . 

2001-present

Paul Coverdell Acute Stroke Registry : Established by the CDC to be state-based registries collecting data to improve stroke care focusing on timely treatment with intravenous tPA. Georgia was one of the first states to receive funding.

2014–2017

DAWN Trial : Clinical trial that changed the standard of care for patients with ischemic stroke by proving the efficacy of thrombectomy (mechanical clot retrieval). Published in the New England Journal of Medicine in 2018 . 

• DAWN highlighted in an episode of Your Fantastic Mind on PBS/Georgia Public Broadcasting

2016–2023

ENRICH Trial : Randomized, multicenter clinical trial establishing benefit of MIPS for patients with ICH in the brain’s lobar region and is expected to change the standard of care for this disease. Published in the New England Journal of Medicine in 2024.

• ENRICH highlighted in an episode of Your Fantastic Mind on PBS/ Georgia Public Broadcasting
• Additional details and a video of MIPS, PR Newswire

Stroke and The Marcus Foundation 

Marcus Stroke and Neuroscience Center : Based at Grady Hospital in downtown Atlanta, the Marcus Center is staffed by faculty physicians from Emory and Morehouse School of Medicine and directed by Michael Frankel , MD.

Expansion of the Marcus Stroke and Neuroscience Center:   Specifically designed to optimize inpatient/outpatient continuity for multi-disciplinary neuroscience care, the Marcus Stroke and Neuroscience Center Outpatient Clinic opened its doors to serve more patients and expand research capabilities.

2018-present

Marcus Stroke Network : Designed to reduce stroke disability and death rates in the “stroke belt” Southeast. Collaboration among Marcus Stroke and Neuroscience Center at Grady Hospital, Emory Brain Health Center, Marcus Neuroscience Institute at Boca Raton Regional Hospital in Florida and the American Heart Association. Also offers Georgia’s first mobile stroke unit . And provided support to add a second neuro-angiography suite to the Marcus Stroke and Neuroscience Center, the first center in the U.S. to embed an angiogram suite into the neurocritical care setting, thereby improving the efficiency and safety of care.

2024–2028

REACH Trial: This multicenter clinical trial will test MIPS for patients with ICH in the brain’s anterior basal ganglia.

• Brain Health Center
• Neuroscience
• School of Medicine
• Partnerships
• News Releases

Recent News

Download emory news photo.

By downloading Emory news media, you agree to the following terms of use:

Creative Commons Attribution-NoDerivatives 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NoDerivatives 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 – Definitions.

• Adapted Material   means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.
• Copyright and Similar Rights   means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section   2(b)(1)-(2)   are not Copyright and Similar Rights.
• Effective Technological Measures   means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.
• Exceptions and Limitations   means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.
• Licensed Material   means the artistic or literary work, database, or other material to which the Licensor applied this Public License.
• Licensed Rights   means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.
• Licensor   means the individual(s) or entity(ies) granting rights under this Public License.
• Share   means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.
• Sui Generis Database Rights   means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.
• You   means the individual or entity exercising the Licensed Rights under this Public License.   Your   has a corresponding meaning.

Section 2 – Scope.

• reproduce and Share the Licensed Material, in whole or in part; and
• produce and reproduce, but not Share, Adapted Material.
• Exceptions and Limitations . For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.
• Term . The term of this Public License is specified in Section   6(a) .
• Media and formats; technical modifications allowed . The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section   2(a)(4)   never produces Adapted Material.
• Offer from the Licensor – Licensed Material . Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.
• No downstream restrictions . You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.
• No endorsement . Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section   3(a)(1)(A)(i) .

Other rights .

• Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.
• Patent and trademark rights are not licensed under this Public License.
• To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties.

Section 3 – License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

Attribution .

If You Share the Licensed Material, You must:

• identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);
• a copyright notice;
• a notice that refers to this Public License;
• a notice that refers to the disclaimer of warranties;
• a URI or hyperlink to the Licensed Material to the extent reasonably practicable;
• indicate if You modified the Licensed Material and retain an indication of any previous modifications; and
• indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.
• You may satisfy the conditions in Section   3(a)(1)   in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.
• If requested by the Licensor, You must remove any of the information required by Section   3(a)(1)(A)   to the extent reasonably practicable.

Section 4 – Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

• for the avoidance of doubt, Section   2(a)(1)   grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database, provided You do not Share Adapted Material;
• if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and
• You must comply with the conditions in Section   3(a)   if You Share all or a substantial portion of the contents of the database.

Section 5 – Disclaimer of Warranties and Limitation of Liability.

• Unless otherwise separately undertaken by the Licensor, to the extent possible, the Licensor offers the Licensed Material as-is and as-available, and makes no representations or warranties of any kind concerning the Licensed Material, whether express, implied, statutory, or other. This includes, without limitation, warranties of title, merchantability, fitness for a particular purpose, non-infringement, absence of latent or other defects, accuracy, or the presence or absence of errors, whether or not known or discoverable. Where disclaimers of warranties are not allowed in full or in part, this disclaimer may not apply to You.
• To the extent possible, in no event will the Licensor be liable to You on any legal theory (including, without limitation, negligence) or otherwise for any direct, special, indirect, incidental, consequential, punitive, exemplary, or other losses, costs, expenses, or damages arising out of this Public License or use of the Licensed Material, even if the Licensor has been advised of the possibility of such losses, costs, expenses, or damages. Where a limitation of liability is not allowed in full or in part, this limitation may not apply to You.
• The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 – Term and Termination.

• This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

Where Your right to use the Licensed Material has terminated under Section   6(a) , it reinstates:

• automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or
• upon express reinstatement by the Licensor.
• For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.
• Sections   1 ,   5 ,   6 ,   7 , and   8   survive termination of this Public License.

Section 7 – Other Terms and Conditions.

• The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.
• Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 – Interpretation.

• For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.
• To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.
• No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.
• Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.

Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the   CC0 Public Domain Dedication . Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at   creativecommons.org/policies , Creative Commons does not authorize the use of the trademark “Creative Commons” or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Virtual Tour

Experience University of Idaho with a virtual tour. Explore now

• Discover a Career
• Find a Major
• Experience U of I Life

More Resources

• Admitted Students
• International Students

Take Action

• Find Financial Aid
• View Deadlines
• Find Your Rep

Helping to ensure U of I is a safe and engaging place for students to learn and be successful. Read about Title IX.

Get Involved

• Clubs & Volunteer Opportunities
• Recreation and Wellbeing
• Student Government
• Student Sustainability Cooperative
• Academic Assistance
• Safety & Security
• Career Services
• Health & Wellness Services
• Register for Classes
• Dates & Deadlines
• Financial Aid
• Sustainable Solutions
• U of I Library

• Upcoming Events

Review the events calendar.

Stay Connected

• Vandal Family Newsletter
• Here We Have Idaho Magazine
• Living on Campus
• Campus Safety
• About Moscow

The largest Vandal Family reunion of the year. Check dates.

Benefits and Services

• Vandal Voyagers Program
• Vandal License Plate
• Submit Class Notes

Make a Gift

• View Events
• Alumni Chapters
• University Magazine
• Alumni Newsletter

SlateConnect

U of I's web-based retention and advising tool provides an efficient way to guide and support students on their road to graduation. Login to SlateConnect.

Common Tools

• Administrative Procedures Manual (APM)
• Class Schedule
• OIT Tech Support
• Academic Dates & Deadlines
• U of I Retirees Association
• Faculty Senate
• Staff Council

University of Idaho Foundation

Physical Address: Mary E. Forney Hall

Mailing Address: University of Idaho Foundation 875 Perimeter Drive MS 3143 Moscow, ID 83844-3143

Phone: 208-885-4000

Fax: 208-885-4040

Gift Administration

Mailing Address: University of Idaho Foundation 875 Perimeter Drive - MS 3143 Moscow, ID 83844-3143

Email: [email protected]

Since 1889 the University of Idaho has been leading Idaho, the Northwest and beyond. From architecture to law, art to science, business to engineering, environment to education, our students, faculty and alumni are pursuing their passions and making our communities richer along the way. Giving to the University of Idaho Foundation helps keep the legacy of leading alive.